The estimated Net Worth of Jaime Contreras is at least $25.4 million dollars as of 21 April 2020. Mr. Contreras owns over 108,412 units of Abbott Laboratories stock worth over $16,957,255 and over the last 11 years he sold ABT stock worth over $8,431,222. In addition, he makes $0 as Senior Vice President - Core Laboratory Diagnostics et Commercial Operations at Abbott Laboratories.
Jaime has made over 26 trades of the Abbott Laboratories stock since 2013, according to the Form 4 filled with the SEC. Most recently he exercised 108,412 units of ABT stock worth $6,192,493 on 21 April 2020.
The largest trade he's ever made was exercising 354,287 units of Abbott Laboratories stock on 30 January 2019 worth over $15,142,226. On average, Jaime trades about 26,984 units every 59 days since 2013. As of 21 April 2020 he still owns at least 145,431 units of Abbott Laboratories stock.
You can see the complete history of Mr. Contreras stock trades at the bottom of the page.
Jaime Contreras serves as Senior Vice President - Core Laboratory Diagnostics, Commercial Operations of the Company. From 2008 to 2013 he was Vice President, Diagnostics, Global Commercial Operations.
Jaime Contreras is 63, he's been the Senior Vice President - Core Laboratory Diagnostics et Commercial Operations of Abbott Laboratories since 2013. There are 8 older and 33 younger executives at Abbott Laboratories. The oldest executive at Abbott Laboratories is Samuel Scott, 75, who is the Independent Director.
Jaime's mailing address filed with the SEC is 100 ABBOTT PARK ROAD, , ABBOTT PARK, IL, 60064.
Over the last 24 years, insiders at Abbott Laboratories have traded over $388,257,551 worth of Abbott Laboratories stock and bought 1,028,477 units worth $44,923,618 . The most active insiders traders include Miles D White, Richard A Gonzalez et Jeffrey M Leiden. On average, Abbott Laboratories executives and independent directors trade stock every 9 days with the average trade being worth of $4,003,344. The most recent stock trade was executed by John A. Jr. Mccoy on 1 September 2024, trading 27 units of ABT stock currently worth $3,100.
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States.
Abbott Laboratories executives and other stock owners filed with the SEC include: